Riccardo Marconcini

3PUBLICATIONS
71CO-AUTHORS
Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 01, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.

Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary

|Mar 28, 2017
Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months.

Riccardo Marconcini, Luca Galli, Andrea Antonuzzo

Pageof 1